China SXT Pharmaceuticals (SXTC) Inventory (2018 - 2025)
China SXT Pharmaceuticals (SXTC) recorded quarterly Inventory of -$775460.0 in Q3 2025, down 357.59% quarter-over-quarter from $301050.0 in Q1 2025, and down 207.51% on a YoY basis from $721318.0 in Q3 2024.
China SXT Pharmaceuticals (SXTC) Inventory (2018 - 2025) Analysis & Trends
China SXT Pharmaceuticals' Inventory history runs 8 years deep, the most recent figure standing at -$775460.0 for Q3 2025.
- In Q3 2025, Inventory fell 207.51% year-over-year to -$775460.0; the TTM figure through Sep 2025 stood at -$775460.0 (down 207.51% YoY), while the FY2025 annual figure was $301050.0, down 62.13% from the prior year.
- Inventory was -$775460.0 for Q3 2025 at China SXT Pharmaceuticals, down from $301050.0 in the prior quarter.
- In the past five years, Inventory ranged from a high of $859696.0 in Q1 2021 to a low of -$775460.0 in Q3 2025.
- Historically, Inventory has averaged $213895.4 across 5 years, with a median of $73115.5 in 2022.
- The sharpest annual moves came in 2024 and 2025: Inventory surged 1616.6% in 2024, then tumbled 207.51% in 2025.
- A 5-year view of Inventory shows it stood at -$5353.0 in 2021, then jumped by 1185.9% to $58128.0 in 2022, then soared by 51.57% to $88103.0 in 2023, then surged by 718.72% to $721318.0 in 2024, then sank by 207.51% to -$775460.0 in 2025.
- The last three Inventory figures came in at -$775460.0 (Q3 2025), $301050.0 (Q1 2025), and $721318.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.55 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 178.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 131.84 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 64.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.72 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 336.70 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 79.07 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 61.34 Mn |
| 10 | China SXT Pharmaceuticals | 187.96 Mn | 166.77 Mn | - | -775,460.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -775,460.00 |
| Mar 31, 2025 | 301,050.00 |
| Sep 30, 2024 | 721,318.00 |
| Mar 31, 2024 | 794,855.00 |
| Sep 30, 2023 | 88,103.00 |
| Mar 31, 2023 | 46,304.00 |
| Sep 30, 2022 | 58,128.00 |
| Mar 31, 2022 | 50,313.00 |
| Sep 30, 2021 | -5,353.00 |
| Mar 31, 2021 | 859,696.00 |
| Sep 30, 2020 | -312,599.00 |
| Mar 31, 2020 | 154,135.00 |
| Sep 30, 2019 | 22,451.00 |
| Mar 31, 2019 | 1.01 Mn |
| Sep 30, 2018 | -119,452.00 |
| Mar 31, 2018 | 227,204.00 |